The Avant-Garde third program is a feature-length presentation of Alla Nazimova’s Salome, a bit of art noveau by way of Hollywood grandeur. Tickets cost $11 for each individual program ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Click here for the full schedule. The Krewe of Druids will start at 6:15 p.m. and will be followed by the Krewe of ALLA. The parades will all be livestreamed on the NOLA.com Parade Cam starting at ...
Head to Revolution Stage Company this week for a compelling production detailing the legacy of Alla Nazimova, a trailblazing icon of stage and screen. This solo show about the acclaimed Russian ...
THAT’S FOLLOWED BY THE KREWE OF ALLA AT 630, WHO, BY THE WAY, THIS YEAR ARE CELEBRATING THEIR FIRST BLACK ROYALTY. ALSO, THEY ARE AT A NEW TIME SLOT, A NEW DAY ON THE ROUTE, MOVING TO TONIGHT ...
Wednesday will be a dreamy night for Gian Durand, when the buoyant New Orleans businesswoman reigns as the first Black queen of the ALLA parade. “I feel like this is a script somebody wrote ...
NEW ORLEANS — The 2025 Carnival season kicked off on January 6, and the the Krewe of ALLA is set to roll on Wednesday, Feb 26, after the Krewe of Druids. The parade starts at the intersection of ...
A “cultural revolution on wheels.” That's how the Krewe of ALLA describes its Mardi Gras parade this year. Named in honor of Algiers, La., the 93-year-old New Orleans krewe rolls through ...
NEW ORLEANS — A new chapter in Mardi Gras history was written as Gian Durand and James Carter were crowned the first Black King and Queen of the Krewe of ALLA, making a bold statement for the 93 ...
A pair of investors will acquire bluebird bio in a deal worth only $29 million upfront after the gene therapy maker ran out of time … ...
Flying high as one of the world’s premier developers of gene therapies in early 2018, bluebird bio’s share price hit a dizzying $2,300 apiece. But seven years later—after failing to build a ...
February 21, 2025--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird") today announced that it has entered into a definitive agreement to be acquired by funds managed by global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback